Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. (CLBS) Stock Overview
Explore Caladrius Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.4M
P/E Ratio
-0.24
EPS (TTM)
$-0.39
ROE
-0.44%
CLBS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Caladrius Biosciences, Inc. (CLBS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.20.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.24 and a market capitalization of 3.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.